Works matching AU Dreyling, Martin
Results: 141
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 1, p. 150, doi. 10.1002/ijc.33202
- By:
- Publication type:
- Article
The role of fludarabine in the treatment of follicular and mantle cell lymphoma.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 5, p. 883
- By:
- Publication type:
- Article
2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma.
- Published in:
- Electrophoresis, 2009, v. 30, n. 6, p. 974, doi. 10.1002/elps.200800508
- By:
- Publication type:
- Article
Proteome- and microarray-based expression analysis of lymphoma cell lines identifies a p53-centered cluster of differentially expressed proteins in mantle cell and follicular lymphoma.
- Published in:
- Electrophoresis, 2007, v. 28, n. 23, p. 4416, doi. 10.1002/elps.200600831
- By:
- Publication type:
- Article
Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.
- Published in:
- Histopathology, 2011, v. 58, n. 4, p. 586, doi. 10.1111/j.1365-2559.2011.03779.x
- By:
- Publication type:
- Article
The expression of activation induced cytidine deaminase in follicular lymphoma is independent of prognosis and stage.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 474, doi. 10.1016/j.clml.2021.12.018
- By:
- Publication type:
- Article
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e886, doi. 10.1016/j.clml.2021.06.021
- By:
- Publication type:
- Article
IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S403, doi. 10.1016/S2152-2650(21)01911-X
- By:
- Publication type:
- Article
Poster: IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S245, doi. 10.1016/S2152-2650(21)01539-1
- By:
- Publication type:
- Article
APRIL and BAFF: novel biomarkers for central nervous system lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0796-4
- By:
- Publication type:
- Article
Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 5, p. 803, doi. 10.1007/s00277-013-1976-x
- By:
- Publication type:
- Article
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 6, p. 847, doi. 10.1007/s00277-011-1377-y
- By:
- Publication type:
- Article
Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 858, doi. 10.1002/hon.3194
- By:
- Publication type:
- Article
Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 36, doi. 10.1002/hon.3149
- By:
- Publication type:
- Article
Mantle cell lymphoma-Advances in molecular biology, prognostication and treatment approaches.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Mantelzelllymphom: Die Kombination verschiedener Therapien führt zum Erfolg.
- Published in:
- Kompass Onkologie, 2022, v. 9, n. 3, p. 105, doi. 10.1159/000526780
- By:
- Publication type:
- Article
Schwere Candida-glabrata-Pankolitis und letale Aspergillus-fumigatus-Lungeninfektion vor dem Hintergrund einer Knochenmarkaplasie nach CD19-spezifischer CAR T-Zell-Therapie – ein Fallbericht.
- Published in:
- Kompass Onkologie, 2021, v. 8, n. 3, p. 159, doi. 10.1159/000518824
- By:
- Publication type:
- Article
Aktuelle und künftige Indikationen mit Bendamustin: chronische lymphatische Leukämie, indolente Lymphome, Mantelzell-Lymphome und diffuse großzellige B-Zell-Lymphome.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, p. 11, doi. 10.1159/000346106
- By:
- Publication type:
- Article
The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00682
- By:
- Publication type:
- Article
Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1618, doi. 10.1093/neuonc/nox097
- By:
- Publication type:
- Article
Are Biosimilars the Future of Oncology and Haematology?
- Published in:
- Drugs, 2019, v. 79, n. 15, p. 1609, doi. 10.1007/s40265-019-01193-y
- By:
- Publication type:
- Article
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date.
- Published in:
- Drugs, 2016, v. 76, n. 6, p. 639, doi. 10.1007/s40265-016-0565-4
- By:
- Publication type:
- Article
Current Management of Mantle Cell Lymphoma.
- Published in:
- Drugs, 2007, v. 67, n. 12, p. 1689, doi. 10.2165/00003495-200767120-00004
- By:
- Publication type:
- Article
Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL) post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic literature review and meta-analysis.
- Published in:
- Leukemia & Lymphoma, 2024, v. 65, n. 11, p. 1609, doi. 10.1080/10428194.2024.2369653
- By:
- Publication type:
- Article
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.
- Published in:
- Leukemia & Lymphoma, 2024, v. 65, n. 1, p. 14, doi. 10.1080/10428194.2023.2268228
- By:
- Publication type:
- Article
Follicular lymphoma: an update on biology and optimal therapy.
- Published in:
- Leukemia & Lymphoma, 2023, v. 64, n. 4, p. 761, doi. 10.1080/10428194.2023.2174804
- By:
- Publication type:
- Article
The role of B cell antigen receptors in mantle cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0533-9
- By:
- Publication type:
- Article
A Closer Look at Copanlisib.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 1, p. 35
- By:
- Publication type:
- Article
Tackling Mantle Cell Lymphoma in Europe.
- Published in:
- Healthcare (2227-9032), 2022, v. 10, n. 9, p. 1682, doi. 10.3390/healthcare10091682
- By:
- Publication type:
- Article
Rituximab Treatment of Hairy Cell Leukemia in a Patient with Mycobacterium kansasii Infection: A Case Report.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 11, p. 637, doi. 10.1159/000519301
- By:
- Publication type:
- Article
CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2503, doi. 10.3390/cancers13102503
- By:
- Publication type:
- Article
3'UTR mediated regulation of the cyclin D1 proto-oncogene.
- Published in:
- Cell Cycle, 2009, v. 8, n. 21, p. 3592, doi. 10.4161/cc.8.21.9993
- By:
- Publication type:
- Article
Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis.
- Published in:
- Nature Medicine, 2014, v. 20, n. 12, p. 1401, doi. 10.1038/nm.3740
- By:
- Publication type:
- Article
Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia – an updated meta‐analysis.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 234, doi. 10.1111/bjh.15901
- By:
- Publication type:
- Article
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 558, doi. 10.1111/bjh.15690
- By:
- Publication type:
- Article
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 616, doi. 10.1111/bjh.15519
- By:
- Publication type:
- Article
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 430, doi. 10.1111/bjh.14870
- By:
- Publication type:
- Article
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 410, doi. 10.1111/bjh.14860
- By:
- Publication type:
- Article
Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 4, p. 606, doi. 10.1111/bjh.13132
- By:
- Publication type:
- Article
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 91, doi. 10.1111/bjh.12853
- By:
- Publication type:
- Article
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 5, p. 565, doi. 10.1111/j.1365-2141.2010.08298.x
- By:
- Publication type:
- Article
Antikörpertherapie maligner Lymphome.
- Published in:
- Medizinische Klinik (Urban & Vogel), 2005, v. 100, n. 1, p. 14, doi. 10.1007/s00063-005-1115-0
- By:
- Publication type:
- Article
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1699, doi. 10.1002/ajh.27056
- By:
- Publication type:
- Article
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 4, p. 362, doi. 10.1002/ajh.25711
- By:
- Publication type:
- Article
The Diagnosis and Treatment of Primary CNS Lymphoma: An Interdisciplinary Challenge.
- Published in:
- Deutsches Ärzteblatt International, 2018, v. 115, n. 25, p. 419, doi. 10.3238/arztebl.2018.0419
- By:
- Publication type:
- Article
Biomarkers and Prognosis in Malignant Lymphomas.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 160
- By:
- Publication type:
- Article
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 3, p. 317, doi. 10.1111/j.1365-2141.2008.07443.x
- By:
- Publication type:
- Article
Current management of follicular lymphomas.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 2, p. 191, doi. 10.1111/j.1365-2141.2006.06378.x
- By:
- Publication type:
- Article